April 09, 2019

The Drug Development Process

The drug development process typically takes years, if not decades, with parallel R&D and financing tracks critical to success. Throughout, effective execution rests on the ability to securely and efficiently share, search and review confidential information with potential investors, regulators, advisors and other internal and external stakeholders.

The following infographic provides insight into 2 key areas in this process:

  • How a drug comes to market
  • The complex exchange of confidential information

You may also like:

2H 2022 M&A Outlook

How is the increasingly turbulent market landscape impacting dealmaker’s M&A outlook for the second half of 2022 and beyond? To understand just what kind of opportunities and challenges lie ahead, Datasite surveyed over 540 dealmakers across five countries to find out.

Talent and diversity in dealmaking

To better understand how dealmakers view diversity, equity and inclusion (DE&I) in their own workplaces and in dealmaking, Datasite surveyed 600 global M&A professionals across the US, UK, Canada, France, Germany and Australia. Following, are some of the key findings.

2022 UK TMT M&A Outlook: Hotspots and Challenges

Technology, media and telecommunications (TMT) was one of the strongest sectors for mergers and acquisitions in 2021, but what's on tap for 2022? Datasite surveyed 200 senior UK M&A professionals, including some CEOs, to find out where the best investment opportunities and challenges lie.